We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Corteva's Seed and Crop Protection Engines Matter to Investors
Read MoreHide Full Article
Key Takeaways
Corteva's two businesses offer investors distinct growth, margin and risk drivers.
Seed organic sales rose 9%, EBITDA climbed 23% and margin expanded about 310 basis points.
Crop Protection volumes rose 6% as cost savings helped lift total operating EBITDA 21%.
Corteva, Inc. (CTVA - Free Report) gives investors exposure to two agriculture technology businesses with different earnings drivers. Seed accounts for 56.9% of total company net sales, while Crop Protection contributes 43.1%.
That balance matters as the company moves toward a planned fourth-quarter 2026 separation. The split could lead investors to value each business on its own growth, margin and risk profile.
Corteva’s Two Engines Support a Balanced Growth Story
Seed and Crop Protection address separate farmer needs. Seed focuses on germplasm and traits that support yield potential and resistance to weather, disease, pests and herbicides. Crop Protection supplies products that protect crops from weeds, insects, other pests and disease.
Image Source: Zacks Investment Research
Both segments are tied to the same farm economy. Crop acreage, commodity prices, farmer income, weather, seasonal planting patterns, currency moves and regional input demand all influence results. The mix can provide resilience when one business faces weaker pricing or seasonal pressure.
That context matters for peers, too. Bayer AG (BAYRY - Free Report) competes across seed, crop protection and digital farming, making it a useful comparison for integrated agriculture technology exposure. FMC Corporation (FMC - Free Report) , with its crop protection focus, offers a cleaner read on chemical demand and pricing conditions.
CTVA Seed Pricing Strengthens Revenue Quality
Corteva’s Seed business delivered 9% organic sales growth in the first quarter of 2026. Price and product mix improved 3%, with gains across all regions, reflecting demand for differentiated technologies and value-based pricing.
This is not simply an acreage story. Brevant retail brand growth, licensing momentum, productivity savings and lower royalty costs are improving revenue quality. Seed operating EBITDA increased 23%, and segment margin expanded about 310 basis points.
Royalty economics are becoming a clearer earnings lever. Corteva recorded a roughly $30 million reduction in net royalty expense in the quarter and now expects Seed to become royalty positive in 2026, ahead of its earlier royalty-neutral target.
Crop Protection showed a different pattern. First-quarter revenues rose 10%, while organic sales increased 4%. Volumes improved 6%, with gains in every region, supported by demand for new products and spinosyn insecticides.
Pricing remains the offset. Segment price declined 2%, mainly due to competitive market dynamics in Latin America and Asia Pacific. Management expects low-single-digit Crop Protection pricing pressure to continue through 2026.
The volume picture still supports the segment’s role in Corteva’s portfolio. Herbicide sales increased 19%, insecticide revenues rose 12% and fungicide sales improved 10% in the quarter. Sustained margin improvement will still depend on mix, productivity and cost control.
CTVA's Cost Savings Expand the Earnings Runway
Corteva’s cost actions are extending the earnings runway beyond volume recovery. Operating EBITDA increased 21% year over year to $1.44 billion in the first quarter, while operating EBITDA margin expanded about 240 basis points to more than 29%.
The company generated roughly $70 million of combined productivity and input-cost benefits across Seed and Crop Protection. Lower Seed royalty costs added another tailwind, helping offset higher selling, general and administrative expenses.
Image Source: Zacks Investment Research
Management reaffirmed its 2026 operating EBITDA outlook of $4.0 billion to $4.2 billion, representing growth of about 7% at the midpoint. The company is also running ahead of its prior three-year, $1 billion cost-reduction plan.
Corteva’s Buy Signal Meets Mixed Style Scores
The bottom line is that Corteva’s two-engine model gives investors both technology-led Seed growth and Crop Protection volume leverage. The planned separation may sharpen that view by allowing the market to evaluate Vylor and the future Corteva separately.
CTVA currently carries a Zacks Rank #2 (Buy), which points to favorable near-term earnings estimate trends. That is a constructive signal for investors who rely on earnings estimate revisions over the next one to three months. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Style Scores are more mixed. CTVA has a Value Score of D, Growth Score of D and VGM Score of D, suggesting the stock does not screen well across those factors. Its Momentum Score of A aligns with recent outperformance, but the weaker Value, Growth and VGM scores argue for a balanced view.
View the Zacks #1 Rank List
Image: Bigstock
Why Corteva's Seed and Crop Protection Engines Matter to Investors
Key Takeaways
Corteva, Inc. (CTVA - Free Report) gives investors exposure to two agriculture technology businesses with different earnings drivers. Seed accounts for 56.9% of total company net sales, while Crop Protection contributes 43.1%.
That balance matters as the company moves toward a planned fourth-quarter 2026 separation. The split could lead investors to value each business on its own growth, margin and risk profile.
Corteva’s Two Engines Support a Balanced Growth Story
Seed and Crop Protection address separate farmer needs. Seed focuses on germplasm and traits that support yield potential and resistance to weather, disease, pests and herbicides. Crop Protection supplies products that protect crops from weeds, insects, other pests and disease.
Image Source: Zacks Investment Research
Both segments are tied to the same farm economy. Crop acreage, commodity prices, farmer income, weather, seasonal planting patterns, currency moves and regional input demand all influence results. The mix can provide resilience when one business faces weaker pricing or seasonal pressure.
That context matters for peers, too. Bayer AG (BAYRY - Free Report) competes across seed, crop protection and digital farming, making it a useful comparison for integrated agriculture technology exposure. FMC Corporation (FMC - Free Report) , with its crop protection focus, offers a cleaner read on chemical demand and pricing conditions.
CTVA Seed Pricing Strengthens Revenue Quality
Corteva’s Seed business delivered 9% organic sales growth in the first quarter of 2026. Price and product mix improved 3%, with gains across all regions, reflecting demand for differentiated technologies and value-based pricing.
This is not simply an acreage story. Brevant retail brand growth, licensing momentum, productivity savings and lower royalty costs are improving revenue quality. Seed operating EBITDA increased 23%, and segment margin expanded about 310 basis points.
Royalty economics are becoming a clearer earnings lever. Corteva recorded a roughly $30 million reduction in net royalty expense in the quarter and now expects Seed to become royalty positive in 2026, ahead of its earlier royalty-neutral target.
Corteva’s Crop Protection Volumes Offset Price Pressure
Crop Protection showed a different pattern. First-quarter revenues rose 10%, while organic sales increased 4%. Volumes improved 6%, with gains in every region, supported by demand for new products and spinosyn insecticides.
Pricing remains the offset. Segment price declined 2%, mainly due to competitive market dynamics in Latin America and Asia Pacific. Management expects low-single-digit Crop Protection pricing pressure to continue through 2026.
The volume picture still supports the segment’s role in Corteva’s portfolio. Herbicide sales increased 19%, insecticide revenues rose 12% and fungicide sales improved 10% in the quarter. Sustained margin improvement will still depend on mix, productivity and cost control.
CTVA's Cost Savings Expand the Earnings Runway
Corteva’s cost actions are extending the earnings runway beyond volume recovery. Operating EBITDA increased 21% year over year to $1.44 billion in the first quarter, while operating EBITDA margin expanded about 240 basis points to more than 29%.
The company generated roughly $70 million of combined productivity and input-cost benefits across Seed and Crop Protection. Lower Seed royalty costs added another tailwind, helping offset higher selling, general and administrative expenses.
Image Source: Zacks Investment Research
Management reaffirmed its 2026 operating EBITDA outlook of $4.0 billion to $4.2 billion, representing growth of about 7% at the midpoint. The company is also running ahead of its prior three-year, $1 billion cost-reduction plan.
Corteva’s Buy Signal Meets Mixed Style Scores
The bottom line is that Corteva’s two-engine model gives investors both technology-led Seed growth and Crop Protection volume leverage. The planned separation may sharpen that view by allowing the market to evaluate Vylor and the future Corteva separately.
CTVA currently carries a Zacks Rank #2 (Buy), which points to favorable near-term earnings estimate trends. That is a constructive signal for investors who rely on earnings estimate revisions over the next one to three months. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Style Scores are more mixed. CTVA has a Value Score of D, Growth Score of D and VGM Score of D, suggesting the stock does not screen well across those factors. Its Momentum Score of A aligns with recent outperformance, but the weaker Value, Growth and VGM scores argue for a balanced view.